These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 3026767)

  • 1. [Transient HIV-antibody positive tests in heart transplantation patients after repeated administration of a CMV immune globulin preparation].
    Flik J; Milbradt H; Wahlers T; Schäfers HJ; Haverich A
    Dtsch Med Wochenschr; 1987 Jan; 112(5):178-81. PubMed ID: 3026767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of an intravenous immunoglobulin preparation: lack of seroconversion for human immunodeficiency virus antibodies.
    Lee ML; Kingdon HS; Hooper J; Courter SG; Holst SL; Piszkiewicz D
    Clin Ther; 1987; 9(3):300-3. PubMed ID: 3111704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune monitoring of anti cytomegalovirus antibodies and risk of cytomegalovirus disease in heart transplantation.
    Sarmiento E; Lanio N; Gallego A; Rodriguez-Molina J; Navarro J; Fernandez-Yañez J; Palomo J; Rodríguez-Hernández C; Ruiz M; Alonso R; Fernandez-Cruz E; Carbone J
    Int Immunopharmacol; 2009 Jun; 9(6):649-52. PubMed ID: 18940269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CMV antigenemia (the lower matrix protein PP65), a marker for the guidance of antiviral therapy in cytomegalovirus disease after orthotopic heart transplantation.
    Iberer F; Tscheliessnigg KH; Halwachs G; Auer T; Wasler A; Petutschnigg B; Müller H; Freigassner M; Allmayr T; Hipmair G
    Wien Klin Wochenschr; 1995; 107(23):718-22. PubMed ID: 8560893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of immunoglobulins and of antibody isotypes in bone marrow transplant recipients treated with high doses of polyspecific immunoglobulin or with cytomegalovirus hyperimmune globulin.
    Gratwohl A; Doran JE; Bachmann P; Scherz R; Späth P; Baumgartner C; Perret B; Berger C; Nissen C; Tichelli A
    Bone Marrow Transplant; 1991 Oct; 8(4):275-82. PubMed ID: 1661632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monitoring of cytomegalovirus disease after heart transplantation: persistence of anti-cytomegalovirus IgM antibodies.
    Iberer F; Halwachs-Baumann G; Rödl S; Pleisnitzer A; Wasler A; Auer T; Petutschnigg B; Müller H; Tscheliessnigg K; Wilders-Truschnig M
    J Heart Lung Transplant; 1994; 13(3):405-11. PubMed ID: 8061015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of cytomegalovirus IgG antibody following infusion of a hyperimmune globulin preparation in allogeneic marrow transplant recipients.
    Reusser P; Osterwalder B; Gratama JW; The TH; Gratwohl A; Speck B
    Bone Marrow Transplant; 1989 May; 4(3):267-72. PubMed ID: 2543469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An enzyme immunoassay based micro-neutralization test for titration of antibodies to human cytomegalovirus (CMV) and its correlation with direct ELISA measuring CMV IgG antibodies.
    Gupta CK; Leszczynski J; Gupta RK; Siber GR
    Biologicals; 1996 Mar; 24(1):41-9. PubMed ID: 8733600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Specific anti-cytomegalovirus immunoglobulins in the prevention of cytomegalovirus infections in bone marrow allografts].
    Huart JJ; Baume D; Jouet JP
    Ann Med Interne (Paris); 1987; 138(5):372-4. PubMed ID: 2823667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of polymerase chain reaction from plasma and buffy coat with antigen detection and occurrence of immunoglobulin M for the demonstration of cytomegalovirus infection after liver transplantation.
    Schmidt CA; Oettle H; Peng R; Neuhaus P; Blumhardt G; Lohmann R; Wilborn F; Osthoff K; Oertel J; Timm H
    Transplantation; 1995 Apr; 59(8):1133-8. PubMed ID: 7732559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent humoral immune defect in highly active antiretroviral therapy-treated children with HIV-1 infection: loss of specific antibodies against attenuated vaccine strains and natural viral infection.
    Bekker V; Scherpbier H; Pajkrt D; Jurriaans S; Zaaijer H; Kuijpers TW
    Pediatrics; 2006 Aug; 118(2):e315-22. PubMed ID: 16847077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytomegalovirus antibody avidity in allogeneic bone marrow recipients: evidence for primary or secondary humoral responses depending on donor immune status.
    Lutz E; Ward KN; Szydlo R; Goldman JM
    J Med Virol; 1996 May; 49(1):61-5. PubMed ID: 8732861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy.
    Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G
    Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Incidence, prevention and therapy of cytomegalovirus and pneumocystis carinii infection after heart transplantation].
    Vetter H; Reichenspurner H; Uberfuhr P; Netz H; Reichart B
    Med Klin (Munich); 1992 Oct; 87 Suppl 1():56-9. PubMed ID: 1334222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies.
    Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E
    Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of a new rapid ELISA technique for detecting human cytomegalovirus antibodies (CMV). Applications in emergency blood transfusion and in organ transplantation].
    Goldschmidt P; Matta M; Cotigny S; Longuet MF; Aimé C; Biglione M; Guillemain R; Amrein C; Farge D
    Ann Biol Clin (Paris); 1993; 51(6):641-8. PubMed ID: 8172403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between the symptomatic cytomegalovirus infection and the fluctuation of anti-CMV antibodies in patient after renal transplantation].
    Miyamoto N; Takamura Y
    Rinsho Byori; 1992 Feb; 40(2):189-93. PubMed ID: 1316499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited cytomegalovirus-specific immunoglobulin M and immunoglobulin G profiles in heart transplant recipients.
    Allen MD; Denny CF; Kruse AP; Revkin JH; Fishbein DP; Ashley RL
    J Heart Lung Transplant; 1991; 10(5 Pt 1):664-73. PubMed ID: 1659902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serologic diagnosis of cytomegalic inclusion disease using the Elisa technic in kidney transplant patients].
    Dennin RH; Herhan J; Schulz E; Sack K
    Dtsch Med Wochenschr; 1984 Feb; 109(6):214-6. PubMed ID: 6321127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety.
    Metselaar HJ; Velzing J; Rothbarth PH; Balk AH; Mochtar B; Weimar W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2504-5. PubMed ID: 2539677
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.